Enobia Pharma Inc.(製薬・医療分野):企業M&A動向

◆英語タイトル:Enobia Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆発行会社/調査会社:GlobalData
◆商品コード:GDPH141517D
◆発行日:2014年4月24日
◆調査対象地域:カナダ
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Enobia Pharma Inc.(製薬・医療分野):企業M&A動向]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Summary

Enobia Pharma Inc. (Enobia) is a privately held biotechnology company. It is principally engaged in the development of therapies to treat serious genetic bone disorders. The company’s lead product, ENB-0040 human recombinant tissue non-specific alkaline phosphatase is targeted enzyme replacement therapy for Hypophosphatasia (HPP). This product is currently under phase II clinical trials. Hypophosphatasia is a rare genetic skeletal abnormal diseases and it is characterized by skeletal related to a deficiency of hypomineralization and its symptoms include the failure of rickets, myopathy, non-traumatic fractures and poor growth. The company received orphan drug designation for this product from the US FDA. Enobia is headquartered in Quebec, Canada.

In December 2011, the company was acquired by Alexion Pharmaceuticals, Inc. for $1.08 Billion.

Enobia Pharma Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Enobia Pharma Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 8
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Enobia Pharma Raises US$15 Million In Venture Financing 9
Enobia Pharma Raises US$50 Million In Series C Financing Round 10
Partnerships 12
McGill Enters Into Collaboration Agreement With Enobia Pharma 12
Equity Offering 13
Enobia Pharma Completes Private Placement Of Common Stock For US$40 Million 13
Acquisition 14
Alexion Pharma Completes Acquisition Of Enobia Pharma 14
Enobia Pharma Inc. – Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Key Facts 1
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Enobia Pharma Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Enobia Pharma Inc., Deals By Therapy Area, 2008 to YTD 2014 7
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 8
Enobia Pharma Raises US$15 Million In Venture Financing 9
Enobia Pharma Raises US$50 Million In Series C Financing Round 10
McGill Enters Into Collaboration Agreement With Enobia Pharma 12
Enobia Pharma Completes Private Placement Of Common Stock For US$40 Million 13
Alexion Pharma Completes Acquisition Of Enobia Pharma 14
Enobia Pharma Inc., Key Competitors 17
Enobia Pharma Inc., Key Employees 18

List of Figures
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 5
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Enobia Pharma Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDPH141517D )"Enobia Pharma Inc.(製薬・医療分野):企業M&A動向" (英文:Enobia Pharma Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。